Sunthornthepvarakul T, Hayashi Y, Refetoff S
Department of Medicine, J.P. Kennedy Jr. Mental Retardation Research Center, University of Chicago, IL.
Thyroid. 1994 Summer;4(2):147-9. doi: 10.1089/thy.1994.4.147.
Sequencing of the human thyrotropin receptor (hTSHR) gene using genomic DNA from peripheral blood leukocytes revealed a substitution of nucleotide 253 in the cDNA sequence. The replacement of the wild-type cytosine-253 to adenine results in the replacement of the wild-type Pro at codon 52 (CCC) with Thr (ACC) located in exon 1 of the TSHR. We screened genomic DNAs from 60 unrelated individuals for the presence of A253 by PCR amplification using a degenerate oligonucleotide primer that produces a Tth111 I restriction site only in the presence of A253. We found 12% having heterozygosity and all had normal free thyroxine index (FT4I) and TSH levels. We have no information concerning the functional significance of this amino acid substitution. However, in the heterozygous state, the variant allele does not result in thyroid function abnormalities.
利用外周血白细胞中的基因组DNA对人促甲状腺激素受体(hTSHR)基因进行测序,结果显示cDNA序列中的第253位核苷酸发生了替换。野生型胞嘧啶-253被腺嘌呤取代,导致TSHR第1外显子中第52位密码子(CCC)处的野生型脯氨酸被苏氨酸(ACC)取代。我们使用一种简并寡核苷酸引物通过PCR扩增从60名无关个体的基因组DNA中筛选A253的存在情况,该引物仅在存在A253时产生Tth111 I限制性酶切位点。我们发现12%的个体具有杂合性,且所有个体的游离甲状腺素指数(FT4I)和促甲状腺激素(TSH)水平均正常。我们没有关于这种氨基酸替换功能意义的信息。然而,在杂合状态下,变异等位基因不会导致甲状腺功能异常。